These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 25025847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer.
    Hafner C, Becker B, Landthaler M, Vogt T.
    Mod Pathol; 2006 Oct; 19(10):1369-77. PubMed ID: 16862074
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
    Sukka-Ganesh B, Mohammed KA, Kaye F, Goldberg EP, Nasreen N.
    BMC Cancer; 2012 Jul 23; 12():309. PubMed ID: 22824143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression analysis of the Epha1 receptor tyrosine kinase and its high-affinity ligands Efna1 and Efna3 during early mouse development.
    Duffy SL, Steiner KA, Tam PP, Boyd AW.
    Gene Expr Patterns; 2006 Oct 23; 6(7):719-23. PubMed ID: 16466970
    [Abstract] [Full Text] [Related]

  • 9. EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma.
    Cui XD, Lee MJ, Yu GR, Kim IH, Yu HC, Song EY, Kim DG.
    Int J Cancer; 2010 Feb 15; 126(4):940-9. PubMed ID: 19642143
    [Abstract] [Full Text] [Related]

  • 10. Architecture of Eph receptor clusters.
    Himanen JP, Yermekbayeva L, Janes PW, Walker JR, Xu K, Atapattu L, Rajashankar KR, Mensinga A, Lackmann M, Nikolov DB, Dhe-Paganon S.
    Proc Natl Acad Sci U S A; 2010 Jun 15; 107(24):10860-5. PubMed ID: 20505120
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma.
    Jin Y, Zou Y, Wan L, Lu M, Liu Y, Huang G, Wang J, Xi Q.
    Mol Med Rep; 2018 Apr 15; 17(4):5409-5415. PubMed ID: 29393455
    [Abstract] [Full Text] [Related]

  • 13. ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
    Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y.
    Oncogene; 2014 Apr 24; 33(17):2179-90. PubMed ID: 23686306
    [Abstract] [Full Text] [Related]

  • 14. [Expression of EphA2 and EphrinA1 in human renal cell carcinoma and its relationship with angiogenesis].
    Xu JS, Zhang JX, Geng TH, Wang YF, Wang XL, Zuo LF.
    Zhonghua Zhong Liu Za Zhi; 2009 Jun 24; 31(6):438-41. PubMed ID: 19950554
    [Abstract] [Full Text] [Related]

  • 15. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
    Wang X, Liu Y, Cao G, Zhang X, Xu H, Xu H, Wang J.
    Int J Clin Exp Pathol; 2015 Jun 24; 8(6):6821-7. PubMed ID: 26261568
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM.
    Cancer Med; 2016 Apr 24; 5(4):656-64. PubMed ID: 26860079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.